Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.75 - $2.24 $37,794 - $112,878
-50,392 Reduced 79.76%
12,785 $12,000
Q3 2022

Nov 14, 2022

BUY
$2.09 - $4.5 $3,028 - $6,520
1,449 Added 2.35%
63,177 $138,000
Q2 2022

Aug 22, 2022

BUY
$2.7 - $5.28 $1,417 - $2,772
525 Added 0.86%
61,728 $216,000
Q1 2022

May 16, 2022

BUY
$4.29 - $6.64 $6,894 - $10,670
1,607 Added 2.7%
61,203 $308,000
Q4 2021

Feb 14, 2022

BUY
$5.77 - $7.96 $1,552 - $2,141
269 Added 0.45%
59,596 $373,000
Q3 2021

Nov 15, 2021

BUY
$6.67 - $9.8 $159,699 - $234,641
23,943 Added 67.67%
59,327 $472,000
Q2 2021

Aug 12, 2021

BUY
$5.06 - $10.78 $128,529 - $273,822
25,401 Added 254.44%
35,384 $264,000
Q1 2021

May 17, 2021

SELL
$5.64 - $23.33 $2,171 - $8,982
-385 Reduced 3.71%
9,983 $60,000
Q4 2020

Feb 12, 2021

BUY
$3.5 - $7.98 $15,025 - $34,258
4,293 Added 70.67%
10,368 $60,000
Q3 2020

Nov 13, 2020

SELL
$4.78 - $16.97 $4,909 - $17,428
-1,027 Reduced 14.46%
6,075 $40,000
Q2 2020

Aug 14, 2020

BUY
$1.68 - $8.85 $11,931 - $62,852
7,102 New
7,102 $63,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.